SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
3044 135 0 MLNM
Emcee:  icanpickem Type:  Unmoderated
Introduction Market Data Compact
Anyone have an interest in MILLENIUM PHARMACEUTICALS--MLNM--a Biotech company with alliances with major Drug companies?
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3044Mark Levin resurfaces as interim ceo of this start up and back to being a vc. rkrw-4/29/2008
3043Within days of the announced buyout, i received a packet from a law firm solicitstylecounciler-4/22/2008
3042Interesting twist for conspiracy theorists - Merrill Lawsuit: if Velcade growintom pope-4/17/2008
3041Takeda/Millennium: The Price is Right invivoblog.blogspot.com Just one week agIcebrg-4/11/2008
3040Not quite the result she had expected. <i>Millennium chief executive DeboIcebrg-4/11/2008
3039Congrats to all longs!..<I'm not one of them..;-(zeta1961-4/10/2008
3038Dunsire joined MLNM in July 2005. The share was at the time trading at around 9 Icebrg-4/10/2008
3037The merger of the company does not surprise me, but it seemed like Johnson &D.Lu-4/10/2008
3036Item 1.01 Entry into a Material Definitive Agreement. Merger Agreement On AIcebrg-4/10/2008
3035Nice! Now I can delete bortezomib from my Pubmed scan. ErikIcebrg-4/10/2008
3034Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer scaram(o)uche-4/10/2008
3033Pulse treatment with the proteasome inhibitor bortezomib inhibits osteoclast resIcebrg-4/10/2008
3032Proteolix is probably the one to watch more closely. rkrw-4/3/2008
3031Yeah, I've posted occasionally about Proteolix and Nereus compounds. How cltuck-4/3/2008
3030Competition for velcade....private co. maybe mlnm could make a bid :) Pressrkrw-4/2/2008
3029Phase I study of capecitabine and oxaliplatin in combination with the proteasomeIcebrg-4/2/2008
3028[Bortezomib, doxorubicin and dexamethasone (PAD) front-line treatment of multipltuck-3/31/2008
3027Ice, MLNM stopped this trial years ago, some believe they no longer have controGary Mohilner-3/29/2008
3026Phase I Trial of the Prostate-Specific Membrane Antigen-Directed ImmunoconjugateIcebrg-3/27/2008
3025Targeting NF-{kappa}B in Waldenstrom macroglobulinemia. Blood. 2008 Mar 11 LelIcebrg-3/19/2008
3024Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma. Ann OncIcebrg-3/19/2008
3023A phase I and pharmacologic study of the combination of bortezomib and pegylatedIcebrg-3/19/2008
3022Phase I and pharmacokinetic study of bortezomib in combination with idarubicin aIcebrg-3/14/2008
3021Bortezomib plus melphalan and prednisone in elderly untreated patients with multIcebrg-3/14/2008
3020A phase I pharmacodynamic trial of bortezomib in combination with doxorubicin inIcebrg-3/14/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News